These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 15232328)
21. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. Tollefson GD; Holman SL Int Clin Psychopharmacol; 1993; 8(4):253-9. PubMed ID: 8277144 [TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [TBL] [Abstract][Full Text] [Related]
23. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391 [TBL] [Abstract][Full Text] [Related]
24. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Berman RM; Darnell AM; Miller HL; Anand A; Charney DS Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956 [TBL] [Abstract][Full Text] [Related]
25. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346 [TBL] [Abstract][Full Text] [Related]
26. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. Zhang WJ; Yang XB; Zhong BL J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773 [TBL] [Abstract][Full Text] [Related]
27. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study. Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221 [TBL] [Abstract][Full Text] [Related]
28. Placebo-controlled treatment trial of depression in elderly physically ill patients. Evans M; Hammond M; Wilson K; Lye M; Copeland J Int J Geriatr Psychiatry; 1997 Aug; 12(8):817-24. PubMed ID: 9283926 [TBL] [Abstract][Full Text] [Related]
29. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
30. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ; Ferrando SJ Am J Psychiatry; 2006 Jan; 163(1):59-66. PubMed ID: 16390890 [TBL] [Abstract][Full Text] [Related]
31. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Rabkin JG; Ferrando SJ; Wagner GJ; Rabkin R Psychoneuroendocrinology; 2000 Jan; 25(1):53-68. PubMed ID: 10633535 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial. Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307 [TBL] [Abstract][Full Text] [Related]
34. Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. Rabkin JG; Wagner GJ; Rabkin R J Clin Psychopharmacol; 1999 Feb; 19(1):19-27. PubMed ID: 9934939 [TBL] [Abstract][Full Text] [Related]
35. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Stewart JW; Quitkin FM; McGrath PJ; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P Arch Gen Psychiatry; 1998 Apr; 55(4):334-43. PubMed ID: 9554429 [TBL] [Abstract][Full Text] [Related]
36. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188 [TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Tollefson GD; Bosomworth JC; Heiligenstein JH; Potvin JH; Holman S Int Psychogeriatr; 1995; 7(1):89-104. PubMed ID: 7579025 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Strik JJ; Honig A; Lousberg R; Lousberg AH; Cheriex EC; Tuynman-Qua HG; Kuijpers PM; Wellens HJ; Van Praag HM Psychosom Med; 2000; 62(6):783-9. PubMed ID: 11138997 [TBL] [Abstract][Full Text] [Related]
39. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Berman RM; Anand A; Cappiello A; Miller HL; Hu XS; Oren DA; Charney DS Biol Psychiatry; 1999 May; 45(9):1170-7. PubMed ID: 10331109 [TBL] [Abstract][Full Text] [Related]